Paragangliomas and paraganglioma syndromes;Paragangliome und Paragangliomsyndrome

Laryngo- Rhino- Otologie

Volumn 90, Issue SUPPL. 1, 2011, Pages

  Boedeker, C ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

glomus tumor; paraganglioma; paraganglioma syndrome; pheochromocytoma; rare diseases

Indexed keywords

SUCCINATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE SUBUNIT D; UNCLASSIFIED DRUG;

ARTICLE; AUTOSOMAL INHERITANCE; CANCER RISK; CANCER SURGERY; GENE MUTATION; HEAD AND NECK CANCER; HETEROZYGOTE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAGANGLIOMA; PHENOTYPE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL;

CHROMOSOME ABERRATIONS; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HETEROZYGOTE DETECTION; HUMANS; MALE; MEMBRANE PROTEINS; OTORHINOLARYNGOLOGIC NEOPLASMS; PARAGANGLIOMA; PHENOTYPE; SEX CHROMOSOME ABERRATIONS; SUCCINATE DEHYDROGENASE; SYNDROME;

EID: 79955495923     PISSN: 09358943     EISSN: 14388685     Source Type: Journal    
DOI: 10.1055/s-0030-1270447     Document Type: Article

References (213)

1. Boedeker CC, Ridder GJ, Neumann HPH, Maier W, Schipper J. Diagnostik, Therapie und Behandlungsergebnisse zervikaler Paragangliome. Laryngo-Rhino-Otol 2004 83 585-592 (Pubitemid 39281082)
2. Schipper J, Boedeker CC, Maier W, Neumann HPH. Paragangliome im Kopf-/Halsbereich Teil 1: Systematik und Diagnostik. HNO 2004 52 569-575 (Pubitemid 38843194)
3. Persky MS, Setton A, Niimi Y, Hartman J, Frank D, Berenstein A. Combined endovascular and surgical treatment of head and neck paragangliomas - a team approach. Head Neck 2002 24 423-431 (Pubitemid 34506701)
4. Boedeker CC, Ridder GJ, Schipper J. Paragangliomas of the head and neck: diagnosis and treatment. Fam Cancer 2005 4 55-59 (Pubitemid 40754846)
5. Boedeker CC, Neumann HPH, Offergeld C, Maier W, Falcioni M, Berlis A, Schipper J. Clinical features of paraganglioma syndromes. Skull Base 2009 19 17-25
6. Lee JH, Barich F, Karnell LH, Robinson RA, Zhen WK, Gantz BJ, Hoffman HAT. National cancer data base report on malignant paragangliomas of the head and neck. Cancer 2002 94 730-737 (Pubitemid 34132302)
7. Baysal BE. Hereditary paraganglioma targets diverse paraganglia. J Med Genet 2002 39 617-622 (Pubitemid 35001714)
8. Argiris A, Mellott A, Spies S. PET scan assessment of chemotherapy response in metastatic paraganglioma. Am J Clin Oncol 2003 26 563-566 (Pubitemid 37523056)
9. Neumann HPH, Pawlu C, Peçzkowska M, Bausch B, McWhinney SR, Muresan M, Buchta M, Franke G, Klisch J, Bley T, Hoegerle S, Boedeker CC, Opocher G, Schipper J, Januszewicz A, Eng C. Distinct clinical features characterize paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 2004 292 943-951 (Pubitemid 39097204)
10. Neumann HPH, Erlic Z, Boedeker CC, Rybicki LA, Robledo M, Hermsen M, Schiavi F, Falcioni M, Kwok P, Bauters C, Lampe K, Fischer M, Edelman E, Benn DE, Robinson BG, Wiegand S, Rasp G, Stuck BA, Hoffmann MM, Sullivan M, Sevilla MA, Weiss MM, Peczkowska M, Kubaszek A, Pigny P, Ward RL, Learoyd D, Croxson M, Zabolotny D, Yaremchuk S, Draf W, Muresan M, Lorenz RR, Knipping S, Strohm M, Dyckhoff G, Matthias C, Reisch N, Preuss SF, Eßer D, Walter MA, Kaftan H, Stöver T, Fottner C, Gorgulla H, Malekpour M, Zarandy MM, Schipper J, Brase C, Glien A, Kühnemund M, Koscielny S, Schwerdtfeger P, Välimäki P, Szyfter W, Finckh U, Zerres K, Cascon A, Opocher G, Ridder GJ, Januszewicz A, Suarez C, Eng C. Clinical Predictors for Germline Mutations in Head and Neck Paraganglioma Patients: Cost Reduction Strategy in Genetic Diagnostic Process as Fall-Out. Can Research 2009 69 3650-3656
11. Maher ER, Eng C. The pressure rises: update on the genetics of pheochromocytoma. Hum Mol Genet 2002 11 2347-2354 (Pubitemid 35174697)
12. Gosepath J, Welkoborsky HJ, Mann W. Untersuchungen zur Biologie und Wachstumsgeschwindigkeit bei Tumoren des Glomus jugolotympanicum und des Glomus caroticum. Laryngo-Rhino-Otol 1998 77 429-433 (Pubitemid 28425537)
13. 18F Dopa whole-body PET - initial results. Radiology 2002 222 507-512 (Pubitemid 34106126)
14. D'Acri AM, Ramos-e-Silva M, Basilio-de-Oliveira C, Cerqueira A, Monteiro D, Pretti G, Longo C, Monteiro E. Multiple glomus tumors: recognition and diagnosis. Skinmed 2002 1 94-98
15. Masson P. Le glomus myo-neuro-arteriel des regions tactiles et ses tumeurs. Lyon chir 1924 21 257
16. Mulligan RM. Chemodectoma in the dog. Am J Pathol 1950 26 680-681
17. Miller RB, Boon MS, Atkins JP, Lowry LD. Vagal paraganglioma: The Jefferson experience. Otolaryngol Head Neck Surg 2000 122 482-487 (Pubitemid 30210661)
18. Sobol SM, Dailey JC. Familial multiple cervical paragangliomas: report of a kindred and review of the literature. Otolaryngol Head Neck Surg 1990 102 382-390 (Pubitemid 20152734)
19. Kollert M, Minovi A, Mangold R, Hendus J, Draf W, Bockmühl U. Paragangliome des Kopf-Hals-Bereiches - Tumorkontrolle, funktionelle Ergebnisse und Lebensqualität nach Operation. Laryngo-Rhino-Otol 2006 85 649-656 (Pubitemid 44407306)
20. Maier W, Marangos N, Laszig R. Paraganglioma as a systemic syndrome: pitfalls and strategies. J Laryngol Otol 1999 113 978-982
21. Pellitteri PK, Rinaldo A, Myssiorek D, Gary Jackson C, Bradley PJ, Devaney KO, Shaha AR, Netterville JL, Manni JJ, Ferlito A. Paragangliomas of the head and neck. Oral Oncol 2004 40 563-575 (Pubitemid 38452675)
22. Biller HF, Lawson W, Som P, Rosenfeld R. Glomus vagale tumors. Ann Otol Rhinol Laryngol 1989 98 21-26 (Pubitemid 19039591)
23. Murphy TE, Huvos AG, Frazell E. Chemodectomas of the glomus intravagale and vagal body tumors, non-chromaffin paragangliomas of the nodose ganglion of the vagus nerve. Ann Surg 1970 172 246-255
24. Ketabchi S, Massi D, Santoro R, Franchi A. Paraganglioma of the nasal cavity: a case report. Eur Arch Otolaryngol 2003 260 336-340 (Pubitemid 36960534)
25. Mouadeb DA, Chandra RK, Kennedy DW, Feldman M. Sinonasal paraganglioma: endoscopic resection with a 4-year follow-up. Head Neck 2003 25 1077-1081 (Pubitemid 37475271)
26. Connor SE, Gleeson MJ, Odell E. Extracranial glomus faciale tumour. J Laryngol Otol 2008 122 986-989
27. Birchler MT, Landau K, Went PT, Stoeckli SJ. Paraganglioma of the cervical sympathetic trunk. Ann Otol Rhinol Laryngol 2002 111 1087-1091 (Pubitemid 36020182)
28. Moyer JS, Bradford CR. Sympathetic paraganglioma as an unusual cause of Horner's syndrome. Head Neck 2001 23 338-342 (Pubitemid 32234113)
29. Del Gaudio JM, Muller S. Diagnosis and treatment of supraglottic laryngeal paraganglioma: report of a case. Head Neck 2004 26 94-98 (Pubitemid 38030157)
30. Hinojar AG, Prieto JR, Munoz E, Hinojar AA. Relapsing paraganglioma of the inferior laryngeal paraganglion: case report and review of the literature. Head Neck 2002 24 95-102 (Pubitemid 34013862)
31. Maisel R, Schmidt D, Pambuccian S. Subglottic laryngeal paraganglioma. Laryngoscope 2003 113 401-405 (Pubitemid 36292860)
32. Kronz JD, Argani P, Udelsman R, Silverberg L, Westra WH. Paraganglioma of the thyroid: two cases that clarify and expand the clinical spectrum. Head Neck 2000 22 621-625 (Pubitemid 30663079)
33. Levy MT, Braun JT, Pennant M, Thompson LD. Primary paraganglioma of the parathyroid: a case report and clinicopathologic review. Head Neck Pathol 2010 4 37-43
34. Harries K, Nunn T, Shah V, Richards D, Manson JM. First reported case of esophageal paraganglioma. A review of the literature of gastrointestinal tract paraganglioma including gangliocytic paraganglioma. Dis Esophagus 2004 17 191-195 (Pubitemid 39076947)
35. Myssiorek D. Head and neck paragangliomas: an overview. Otolaryngol Clin North Am 2001 34 829-836 (Pubitemid 33000975)
36. Wang SJ, Wang MB, Barauskas TM, Calcaterra TC. Surgical management of carotid body tumors. Otolaryngol Head Neck Surg 2000 123 202-206
37. Frühwirth J, Koch G, Klein GE. Die präoperative angiografische Embolisation von Tumoren des Karotisglomus. HNO 1996 44 510-513 (Pubitemid 26316589)
38. Smit AA, Timmers HJ, Wieling W, Wagenaar M, Marres HA, Lenders JW, van Montfrans GA, Karemaker JM. Long-term effects of carotid sinus denervation on arterial blood pressure in humans. Circulation 2002 105 1329-1335 (Pubitemid 34260424)
39. Timmers HJ, Karemaker JM, Wieling W, Marres HA, Folgering HT, Lenders JW. Baroreflex and chemoreflex function after bilateral carotid body tumor resection. J Hypertens 2003 21 591-599 (Pubitemid 36418972)
40. Strutz J, Mann W. Praxis der HNO-Heilkunde, Kopf- und Halschirurgie. Stuttgart Thieme 2000 538
41. Braun S, Riemann K, Pusch CM, Sotlar K, Pfister M, Kupka S. Paragangliome der Kopf-Hals-Region. Ein Überblick über die molekulargenetische Forschung. HNO 2004 52 11-17 (Pubitemid 38176037)
42. Rodriguez-Cuevas S, Lopez-Garza J, Labastida-Almendaro S. Carotid body tumors in inhabitants of altitudes higher than 2000 meters above sea level. Head Neck 1998 20 374-378 (Pubitemid 28288058)
43. Astrom K, Cohen JE, Willett-Brozick JE, Aston CE, Baysal BE. Altitude is a phenotypic modifier in hereditary paraganglioma type 1: evidence for an oxygen-sensing defect. Hum Genet 2003 113 228-237 (Pubitemid 36992281)
44. Hajnzic TF, Kruslin B, Belicza M. Carotid body paraganglioma in a nine-year-old boy with extensive pulmonary metastases. Med Pediatr Oncol 1999 32 399-400 (Pubitemid 29196296)
45. Westerband A, Hunter GC, Cintora I, Coulthard SW, Hinni ML, Gentile AT, Devine J, Mills JL. Current trends in the detection and management of carotid body tumors. Vasc Surg 1998 28 84-93 (Pubitemid 28347640)
46. Gstoettner W, Matula C, Hamzavi J, Kornfehl J, Czerny C. Long-term results of different treatment modalities in 37 patients with glomus jugulare tumors. Eur Arch Otorhinolaryngol 1999 256 351-355 (Pubitemid 29427901)
47. Hinerman RW, Mendenhall WM, Amdur RJ, Stringer SP, Antonelli PJ, Cassisi NJ. Definitive radiotherapy in the management of chemodectomas arising in the temporal bone, carotid body and glomus vagale. Head Neck 2001 23 363-371 (Pubitemid 32319483)
48. Patetsios P, Gable DR, Garrett WV, Lamont JP, Kuhn JA, Shutze WP, Kourlis H, Grimsley B, Pearl GJ, Smith BL, Talkington CM, Thompson JE. Management of carotid body paragangliomas and review of a 30-year experience. Ann Vasc Surg 2002 16 331-338 (Pubitemid 34761165)
49. Schick B, Draf W, Kahle G. Jugulotympanale Paragangliome: Therapiekonzepte in der Entwicklung. Laryngo-Rhino-Otol 1998 77 434-443 (Pubitemid 28425538)
50. Gehrking E, Gliemroth J, Missler U, Remmert S. Hauptsymptom: Pulssynchrones Ohrgeräusch Laryngo-Rhino-Otol 2000 79 510-516
51. Groblewski JC, Thekdi A, Carrau RL. Secreting vagal paraganglioma. Am J Otolaryngol 2004 25 295-300
52. Koch CA, Rodbard JS, Brouwers FM, Eisenhofer G, Pacak K. Hypotension in a woman with a metastatic dopamine-secreting carotid body tumor. Endocr Pract 2003 9 310-314
53. Kaftan H, Draf W. Erfahrungen mit der farbkodierten Duplexsonografie im HNO-Bereich. HNO 1999 47 287-291 (Pubitemid 29232471)
54. Stoeckli SJ, Schuknecht B, Alkadhi H, Fisch U. Evaluation of paragangliomas presenting as a cervical mass on color-coded doppler sonography. Laryngoscope 2002 112 143-146 (Pubitemid 34037752)
55. Alkadhi H, Schuknecht B, Stoeckli SJ, Valavanis A. Evaluation of topography and vascularization of cervical paragangliomas by magnetic resonance imaging and color duplex sonography. Neuroradiology 2002 44 83-90 (Pubitemid 36075891)
56. Thabet MH, Kotob H. Cervical paragangliomas: diagnosis, management and complications. J Laryngol Otol 2001 115 467-474 (Pubitemid 32684568)
57. 18F-Dopa positron emission tomography for the detection of glomus tumors. Eur J Nucl Med Mol Imaging 2003 30 689-694 (Pubitemid 36612951)
58. Shamblin WR, Re Mine WH, Sheps SG, Harrison EG Jr. Carotid body tumour. Clinicopathologic analysis of ninety cases. Am J Surg 1971 122 732-739
59. Schipper J, Boedeker CC, Maier W, Neumann HPH. Paragangliome im Kopf-/Halsbereich Teil 2: Therapie und Nachsorge. HNO 2004 52 651-662
60. Fisch U, Mattox D. Microsurgery of the skull base. Stuttgart, New York; Thieme Verlag 1988 149-153
61. Aschenbach R, Esser D. Magnetresonanztomografie im Kopf-Hals-Bereich. HNO 2004 52 77-89
62. Bustillo A, Telischi F, Weed D, Civantos F, Angeli S, Serafini A, Whiteman M. Octreotide scintigraphy in the head and neck. Laryngoscope. 114 434-440 2004
63. Bustillo A, Telischi F. Octreotide scintigraphy in the detection of recurrent paragangliomas. Otolaryngol Head Neck Surg 2004 130 479-482 (Pubitemid 38509541)
64. King KS, Whatley MA, Alexopoulos DK, Reynolds JC, Chen CC, Mattox DE, Jacobs S, Pacak K. The use of functional imaging in a patient with head and neck paragangliomas. J Clin Endocrinol Metab 2010 95 481-482
65. Luster M, Karges W, Zeich K, Pauls S, Verburg FA, Dralle H, Glatting G, Buck AK, Solbach C, Neumaier B, Reske SN, Mottaghy FM. Clinical value of 18F-fluorodihydroxyphenylalanine positron emission tomography/computed tomography (18F-DOPA PET/CT) for detecting pheochromocytoma. Eur J Nucl Med Mol Imaging 2010 37 484-493
66. Kayani I, Bomanji JB, Groves A, Conway G, Gacinovic S, Win T, Dickson J, Caplin M, Ell PJ. Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and 18F-FDG. Cancer 2008 112 2447-2455
67. Srirajaskanthan R, Kayani I, Quigley AM, Soh J, Caplin ME, Bomanji J. The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on 111In-DTPA-octreotide scintigraphy. vJ Nucl Med 2010 51 875-882
68. Chuah KL, Tan PH, Chong YY. Test and teach. Number ninety-three: Part 1. Carotid body paraganglioma. Pathology 1999 31 215-216, 273-274
69. Jaffer S, Harpaz N. Mesenteric paraganglioma: a case report and review of the literature. Arch Pathol Lab Med 2002 126 362-364 (Pubitemid 34208132)
70. Kontogeorgos G, Scheithauer BW, Kovacs K, Horvath E, Melmed S. Growth factors and cytokines in paragangliomas and pheochromocytomas, with special reference to sustentacular cells. Endocr Pathol 2002 13 197-206 (Pubitemid 36021031)
71. Shibahara J, Goto A, Niki T, Tanaka M, Nakajima J, Fukayama M. Primary pulmonary paraganglioma: report of a functioning case with immunohistochemical and ultrastructural study. Am J Surg Pathol 2004 28 825-829 (Pubitemid 38685899)
72. Douwes Dekker PB, Corver WE, Hogendoorn PC, van der Mey AG, Cornelisse CJ. Multiparameter DNA flow-sorting demonstrates diploidy and SDHC wild-type gene retention in the sustentacular cell compartment of head and neck paragangliomas: chief cells are the only neoplastic component. J Pathol 2004 202 456-462 (Pubitemid 38456164)
73. Effat KG, Karam M. Jugulotympanic paraganglioma (glomus tumour) presenting with recurrent epistaxis. J Laryngol Otol 2004 118 153-155 (Pubitemid 38250855)
74. Rinaldo A, Myssiorek D, Devaney KO, Ferlito A. Which paragangliomas of the head and neck have a higher rate of malignancy? Oral Oncol 2004 40 458-460 (Pubitemid 38296829)
75. Au WY, Chan AC, Wong KK, Leung CY, Liang R, Kwong YL. Multiple osseous metastases from occult paraganglioma: a diagnostic pitfall. Histopathology 1998 33 287-288 (Pubitemid 28430522)
76. Kawai A, Healey JH, Wilson SC, Huvos AG, Yeh SD. Carotid body paraganglioma metastatic to bone: report of two cases. Skeletal Radiol 1998 27 103-107 (Pubitemid 28181737)
77. Pacheco-Ojeda L. Malignant carotid body tumors: report of three cases. Ann Otol Rhinol Laryngol 2001 110 36-40 (Pubitemid 32096804)
78. Righini Ch, Pecher M, Halimi S, Magne JL, Reyt E. Malignant carotid paraganglioma. A case report. Ann Otolaryngol Chir Cervicofac 2003 120 103-108
79. Ferris EJ, Smith PL, Boyd CM, Wetzel WJ. Malignant non-chromaffin paraganglioma with metastases to the kidneys. Br J Urol 1983 55 332-334 (Pubitemid 13096542)
80. Wesche WA, Khare VK, Chesney TM, Jenkins JJ. Non-hematopoietic cutaneous metastases in children and adolescents: thirty years experience at St. Jude Children's Research Hospital. J Cutan Pathol 2000 27 485-492
81. Kumaki N, Kajiwara H, Kameyama K, DeLellis RA, Asa SL, Osamura RY, Takami H. Prediction of malignant behavior of pheochromocytomas and paragangliomas using immunohistochemical techniques. Endocr Pathol 2002 13 149-156 (Pubitemid 34828138)
82. Zaharopoulos P. Diagnostic challenges in the fine-needle aspiration diagnosis of carotid body paragangliomas: report of two cases. Diagn Cytopathol 2000 23 202-207 (Pubitemid 30660428)
83. Monabati A, Hodjati H, Kumar PV. Cytologic findings in carotid body tumors. Acta Cytol 2002 46 1101-1104 (Pubitemid 35332625)
84. Jahnke V, Klingebiel R. Pulssynchroner Tinnitus. HNO 2004 52 440-442 (Pubitemid 38649351)
85. Schikschneit M, Maier W, Kayser G, Berlis A, Boedeker CC. Amputation neuroma of the middle ear mimicking glomus tympanicum tumor. Otolaryngol Head Neck Surg 2007 137 843-844 (Pubitemid 47632913)
86. Kollert M, Minovi AA, Draf W, Bockmühl U. Cervical paragangliomas - tumor control and long-term functional results after surgery. Skull Base 2006 16 185-191
87. Feigenberg SJ, Mendenhall WM, Hinerman RW, Amdur RJ, Friedman WA, Antonelli PJ. Radiosurgery for paraganglioma of the temporal bone. Head Neck 2002 24 384-389 (Pubitemid 34260043)
88. Foote RL, Pollock BE, Gorman DA, Schomberg PJ, Stafford SL, Link MJ, Kline RW, Strome SE, Kasperbauer JL, Olsen KD. Glomus jugulare tumor: tumor control and complications after stereotactic radiosurgery. Head Neck 2002 24 332-338 (Pubitemid 34260035)
89. Litle VR, Reilly LM, Ramos TK. Preoperative embolisation of carotid body tumors: when is it appropriate? Ann Vasc Surg 1996 10 464-468 (Pubitemid 26358966)
90. Liapis CD, Evangelidakis EL, Papavassiliou VG, Kakisis JD, Gougoulakis AG, Polyzos AK, Sechas MN, Gogas JG. Role of malignancy and preoperative embolization in the management of carotid body tumors. World J Surg 2000 24 1526-1530 (Pubitemid 32047282)
91. Boyle JO, Shimm DS, Coulthard SW. Radiation therapy for paragangliomas of the temporal bone. Laryngoscope 1990 100 896-901 (Pubitemid 20244852)
92. Elshaikh MA, Mahmoud-Ahmed AS, Kinney SE, Wood BG, Lee JH, Barnett GH, Suh JH. Recurrent head-and-neck chemodectomas: A comparison of surgical and radiotherapeutic results. Int J Rad Oncol Biol Phys 2002 52 953-956 (Pubitemid 34219013)
93. Powell S, Peters N, Harmer C. Chemodectoma of the head and neck: Results of treatment in 84 patients. Int J Radiat Oncol Biol Phys 1992 22 919-924
94. Hinerman RW, Mendenhall WM, Amdur RJ, Feigenberg SJ. Editorial comment: Stereotactic radiosurgery for glomus jugulare tumor. Head Neck 2002 24 338-339
95. Matthews FS. Surgery of the neck. In: Johnson AB (ed.): Operative therapeutics. Vol. 3. East Norwalk, Conn. Appleton-Century-Croft 1915 315
96. Grotemeyer D, Loghmanieh SM, Pourhassan S, Sagban TA, Iskandar F, Reinecke P, Sandmann W. Dignität von Glomus-caroticum-Tumoren. Chirurg 2009 80 854-863
97. Erickson D, Kudva YC, Ebersold MJ, Thompson GB, Grant CS, van Heerden JA, Young WF Jr. Benign paragangliomas. Clinical presentation and treatment outcomes in 236 patients. J Clin Endocrinol Metab 2001 86 5210-5216 (Pubitemid 33070237)
98. Tewari M, Dixit A, Mongha R, Shukla HS. Control of intra-operative hemorrhage during excision of carotid body tumor. J Surg Oncol 2004 85 55-57 (Pubitemid 38036741)
99. van der Mey AG, Jansen JC, van Baalen JM. Management of carotid body tumors. Otolaryngol Clin North Am 2001 34 907-924 (Pubitemid 33000980)
100. Robbins KT, Clayman G, Levine PA, Medina J, Sessions R, Shaha A, Som P, Wolf GT. American Head and Neck Society. Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology - Head and Neck Surgery. Arch Otolaryngol Head Neck Surg 2002 128 751-758 (Pubitemid 34755299)
101. Anand VK, Alemar GO, Sanders TS. Management of the internal carotid artery during carotid body tumour surgery. Laryngoscope 1995 105 231-235
102. Kim JA, Elkon D, Lim ML, Constable WC. Optimum dose of radiotherapy for chemodectomas of the middle ear. Int J Radiat Oncol Biol Phys 1980 6 815-819 (Pubitemid 10015030)
103. Lalwani AK, Jackler RK, Gutin PH. Lethal fibrosarcoma complicating radiation therapy for benign glomus jugulare tumor. Am J Otol 1993 14 398-402 (Pubitemid 23246620)
104. Fisch U. Infratemporal fossa approach for glomus tumors of the temporal bone. Ann Otol Rhinol Laryngol 1982 91 474-479 (Pubitemid 12000825)
105. Fisch U. Infratemporal fossa approach for lesions in the temporal bone and base of the skull. Adv Otorhinolaryngol 1984 34 254-266
106. Hawthorne MR, Makek MS, Harris JP, Fisch U. The histopathological and clinical features of irradiated and nonirradiated temporal paragangliomas. Laryngoscope 1998 98 325-331
107. Lenarz T, Plinkert PK. Glomustumoren des Felsenbeins - operatives Konzept und Ergebnisse. Laryngo-Rhino-Otol 1992 71 149-157
108. Manolidis S, Shohet JA, Jackson G, Glasscock ME. Malignant glomus tumors. Laryngoscope 1999 109 30-33
109. Forest JA III, Jackson CG, McGrew BM. Long-term control of surgically treated glomus tympanicum tumors. Otol Neurotol 2001 22 232-236 (Pubitemid 32233481)
110. Schipper J, Arapakis I, Ridder GJ, Maier W, Spetzger U. Resektion von Foramen-jugulare-Tumoren mit vollständigem Hörerhalt - Mikrochirurgie ohne Transposition des N. facialis. HNO 2003 51 721-727 (Pubitemid 37139549)
111. Gjuric M, Seidinger L, Wigand ME. Long-term results of surgery for temporal bone paraganglioma. Skull Base Surg 1996 6 147-152
112. Jackson CG, Haynes DS, Walker PA, Glasscock ME III, Storper IS, Josey AF. Hearing conservation in surgery for glomus jugulare tumors. Am J Otolaryngol 1996 17 425-437 (Pubitemid 26266579)
113. Murphy TP, Brackmann DE. Effects of preoperative embolization on glomus jugulare tumors. Laryngoscope 1989 99 1244-1247 (Pubitemid 20012644)
114. O'Leary MJ, Shelton C, Giddings NA, Kwartler J, Brackmann DE. Glomus tympanicum tumors: A clinical perspective. Laryngoscope 1991 101 1038-1043
115. Glasscock ME, Harris PF, Newsome G. Glomus tumors: diagnosis and treatment. Laryngoscope 1974 84 2006-2032
116. Chino JP, Sampson JH, Tucci DL, Brizel DM, Kirkpatrick JP. Paraganglioma of the head and neck: long-term local control with radiotherapy. Am J Clin Oncol 2009 32 304-307
117. Steinberg N, Holz WG. Glomus jugularis tumors. Arch Otolaryngol 1965 82 387-394
118. Schulz-Ertner D, Nikoghosyan A, Thilmann C, Haberer T, Jakel O, Karger C, Kraft G, Wannenmacher M, Debus J. Results of carbon ion radiotherapy in 152 patients. Int J Radiat Oncol Biol Phys 2004 58 631-640 (Pubitemid 38142491)
119. Karger CP, Jäkel O. Current status and new developments in ion therapy. Strahlenther Onkol 2007 183 295-300 (Pubitemid 46996066)
120. Laramore GE. Role of particle radiotherapy in the management of head and neck cancer. Curr Opin Oncol 2009 21 224-231
121. Plukker JT, Brongers EP, Vermey A, Krikke A, van den Dungen JJ. Outcome of surgical treatment for carotid body paraganglioma. Br J Surg 2001 88 1382-1386 (Pubitemid 32955421)
122. Velegrakis G, Kalikakis G, Karampekios S, Stefanaki K, Helidonis E. Bilaterales Paragangliom des Nervus vagus. HNO 2001 49 471-475 (Pubitemid 32538755)
123. Marangos N, Schumacher M. Management eines großen bilateralen Glomus jugulare Tumors. HNO 1999 47 816-820 (Pubitemid 29462869)
124. Tikkakoski T, Luotonen J, Leinonen S, Siniluoto T, Heikkilä O, Päivänsalo M, Hyrynkangas K. Preoperative embolization in the management of neck paragangliomas. Laryngoscope 1997 107 821-826 (Pubitemid 27251007)
125. Marangos N, Schumacher M. Facial palsy after glomus jugulare tumour embolization. J Laryngol Otol 1999 113 268-270 (Pubitemid 29116739)
126. Horowitz M, Whisnant RE, Jungreis C, Snyderman C, Levy EI, Kassam A. Temporary balloon occlusion and ethanol injection for preoperative embolization of carotid-body tumor. Ear Nose Throat J 2002 81 536-538, 540, 542
127. Herdman RCD, Gillespie JE, Ramsden RT. Facial palsy after glomus tumour embolization. J Laryngol Otol 1993 107 963-966 (Pubitemid 23320831)
128. Schick PM, Hieshima GB, White RA, Fiaschetti FL, Mehringer CM, Grinnell VS, Everhart FR. Arterial catheter embolization followed by surgery for large chemodectoma. Surgery 1980 87 459-464 (Pubitemid 10138680)
129. Kafie FE, Freischlag JA. Carotid body tumors: the role of preoperative embolization. Ann Vasc Surg 2001 15 237-242 (Pubitemid 32268544)
130. Rödl W, Manzke E. Angiographic differential diagnosis of tumors of the glomus caroticum and jugulo-tympanicum and of arterio-venous shunts in the head and neck. Ann Radiol 1980 23 732-739
131. Hekster RE, Luyendijk W, Matricali B. Transfemoral catheter embolization: a method of treatment of glomus jugulare tumors. Neuroradiology 1973 5 208-214
132. Green JD, Brackmann DE, Nguyen CD, Arriage MA, Telischi FF, De La Cruz A. Surgical management of previously untreated glomus jugulare tumors. Laryngoscope 1994 104 917-921 (Pubitemid 24245055)
133. Tasar M, Yetiser S. Glomus tumors: therapeutic role of selective embolization. J Craniofac Surg 2004 15 497-505
134. Ansari MS, Goel A, Goel S, Durairajan LN, Seth A. Malignant paraganglioma of the urinary bladder. A case report. Int Urol Nephrol 2001 33 343-345
135. Carroll W, Stenson K, Stringer S. Malignant carotid body tumor. Head Neck 2004 26 301-306 (Pubitemid 38292742)
136. Young AL, Baysal BE, Deb A, Young WF Jr. Familial malignant catecholamine-secreting paraganglioma with prolonged survival associated with mutation in the succinate dehydrogenase B gene. J Clin Endocrinol Metab 2002 87 4101-4105
137. Tenenbaum F, Schlumberger M, Lumbroso J, Parmentier C. Beneficial effects of octreotide in a patient with a metastatic paraganglioma. Eur J Cancer 1996 32A 737
138. Troncone L, Rufini V. Nuclear medicine therapy of pheochromocytoma and paraganglioma. Q J Nucl Med 1999 43 344-355 (Pubitemid 30113563)
139. Garkavij M, Nickel M, Sjögreen-Gleisner K, Ljungberg M, Ohlsson T, Wingårdh K, Strand SE, Tennvall J. 177Lu-[DOTA0,Tyr3] octreotate therapy in patients with disseminated neuroendocrine tumors: Analysis of dosimetry with impact on future therapeutic strategy. Cancer 2010 116 4 Suppl 1084-1092
140. Boedeker CC, Neumann HPH, Ridder GJ, Maier W, Schipper J. Paragangliomas in patients with mutations of the SDHD gene. Otolaryngol Head Neck Surg 2005 132 467-470 (Pubitemid 40326702)
141. Boedeker CC, Neumann HPH, Bausch B, Maier W, Schipper J, Ridder GJ. Malignant paragangliomas in SDHB mutation carriers. Otolaryngol Head Neck Surg 2007 137 126-129 (Pubitemid 46962136)
142. Baysal BE. Clinical and molecular progress in hereditary paraganglioma. J Med Genet 2008 45 689-694
143. Baysal BE, Ferrell RE, Willett-Brozick JE, Lawrence EC, Myssiorek D, Bosch A, van der Mey A, Taschner PE, Rubinstein WS, Myers EN, Richard CW 3rd, Cornelisse CJ, Devilee P, Devlin B. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 2000 287 848-851 (Pubitemid 30084326)
144. Baysal BE, Willett-Brozick JE, Lawrence EC, Drovdlic CM, Savul SA, McLeod DR, Yee HA, Brackmann DE, Slattery WH 3rd, Myers EN, Ferrell RE, Rubinstein WS. Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas. J Med Genet 2002 39 178-183 (Pubitemid 34252553)
145. Baysal BE. On the association of succinate dehydrogenase mutations with hereditary paraganglioma. Trends Endocrinol Metab 2003 14 453-459 (Pubitemid 37517346)
146. Neumann HP, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, Schipper J, Klisch J, Altehoefer C, Zerres K, Januszewicz A, Eng C, Smith WM, Munk R, Manz T, Glaesker S, Apel TW, Treier M, Reineke M, Walz MK, Hoang-Vu C, Brauckhoff M, Klein-Franke A, Klose P, Schmidt H, Maier-Woelfle M, Peczkowska M, Szmigielski C, Eng C. Freiburg-Warsaw-Columbus Pheochromocytoma Study Group. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 2002 346 1459-1466
147. Pasini B, Stratakis CA. SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes. J Intern Med 2009 266 19-42
148. Gimm O, Armanios M, Dziema H, Neumann HPH, Eng C. Somatic and occult germline mutations in SDHD, a mitochondrial complex II gene, in non-familial pheochromocytomas. Cancer Res 2000 60 6822-6825 (Pubitemid 32059145)
149. Gimm O, Koch CA, Januszewicz A, Opocher G, Neumann HP. The genetic basis of pheochromocytoma. Front Horm Res 2004 31 45-60
150. Yip L, Lee JR, Shapiro SE, Waguespack SG, Sherman SI, Hoff AO, Gagel RF, Arens JF, Evans DB. Surgical management of hereditary pheochromocytoma. J Am Coll Surg 2004 198 525-535
151. Eng C, Clayton D, Schuffenecker I, Lenoir G, Cote G, Gagel RF, van Amstel HK, Lips CJ, Nishisho I, Takai SI, Marsh DJ, Robinson BG, Frank-Raue K, Raue F, Xue F, Noll WW, Romei C, Pacini F, Fink M, Niederle B, Zedenius J, Nordenskjold M, Komminoth P, Hendy GN, Mulligan LM. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA 1996 276 1575-1579 (Pubitemid 26384740)
152. Frank-Raue K, Hoppner W, Frilling A, Kotzerke J, Dralle H, Haase R, Mann K, Seif F, Kirchner R, Rendl J, Deckart HF, Ritter MM, Hampel R, Klempa J, Scholz GH, Raue F. Mutations of the ret protooncogene in German multiple endocrine neoplasia families: relation between genotype and phenotype. German Medullary Thyroid Carcinoma Study Group. J Clin Endocrinol Metab 1996 81 1780-1783 (Pubitemid 26152463)
153. Shapiro SE, Cote GC, Lee JE, Gagel RF, Evans DB. The role of genetics in the surgical management of familial endocrinopathy syndromes. J Am Coll Surg 2003 197 818-831 (Pubitemid 38199586)
154. Walther MM, Reiter R, Keiser HR, Choyke PL, Venzon D, Hurley K, Gnarra JR, Reynolds JC, Glenn GM, Zbar B, Linehan WM. Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma. J Urol 1999 162 659-664 (Pubitemid 29436843)
155. Walther MM, Herring J, Enquist E, Keiser HR, Linehan WM. von Recklinghausen's disease and pheochromocytomas. J Urol 1999 162 1582-1586 (Pubitemid 29474665)
156. Bausch B, Borozdin W, Neumann HP. European-American Pheochromocytoma Study Group. Clinical and genetic characteristics of patients with neurofibromatosis type 1 and pheochromocytoma. N Engl J Med 2006 354 2729-2731
157. Chase WH. Familial and bilateral tumors of the carotid body. J Pathol Bact 1933 36 1-12
158. Goekoop C. Fibrohaemangioma des Felsenbeines und des Mittelohres bei drei Schwestern. Acta Otolaryngol 1933 18 153-162
159. Linn H, Proctor B. Tumour of the gangliom nodosum of the vagus nerve. Laryngoscope 1956 66 1577-1581
160. Niemann S, Müller U. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nature Genet 2000 26 268-270
161. Astuti D, Latif F, Dallol A, Dahia PLM, Douglas F, George E, Sköldberg F, Husebye ES, Eng C, Maher ER. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 2001 69 49-54 (Pubitemid 32614017)
162. Cascon A, Ruiz-Llorente, Cebrian A, Telleria D, Rivero JC, Diez JJ, Lopez-Ibarra PJ, Jaunsolo MA, Benitez J, Robledo M. Identification of novel SDHD
163. Burnichon N, Brière JJ, Libé R, Vescovo L, Rivière J, Tissier F, Jouanno E, Jeunemaitre X, Bénit P, Tzagoloff A, Rustin P, Bertherat J, Favier J, Gimenez-Roqueplo AP. SDHA is a tumor suppressor gene causing paraganglioma. Hum Mol Genet 2010 19 3011-3020
164. Gimenez-Roqueplo AP, Favier J, Rustin P, Rieubland C, Crespin M, Nau V, Khau Van Kien P, Corvol P, Plouin PF, Jeunemaitre X. COMETE Network. Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. Cancer Res 2003 63 5615-5621 (Pubitemid 37139886)
165. Niemann S, Müller U, Engelhardt D, Lohse P. Autosomal dominant malignant and catecholamine-producing paraganglioma caused by a splice donor site mutation in SDHC. Hum Genet 2003 113 92-94 (Pubitemid 36869043)
166. Hao HX, Khalimonchuk O, Schraders M, Dephoure N, Bayley JP, Kunst H, Devilee P, Cremers CW, Schiffman JD, Bentz BG, Gygi SP, Winge DR, Kremer H, Rutter J. SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma. Science 2009 325 1139-1142
167. Bayley JP, Kunst HP, Cascon A, Sampietro ML, Gaal J, Korpershoek E, Hinojar-Gutierrez A, Timmers HJ, Hoefsloot LH, Hermsen MA, Suárez C, Hussain AK, Vriends AH, Hes FJ, Jansen JC, Tops CM, Corssmit EP, de Knijff P, Lenders JW, Cremers CW, Devilee P, Dinjens WN, de Krijger RR, Robledo M. SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma. Lancet Oncol 2010 11 366-372
168. Eng C, Kiuru M, Fernandez MJ, Aaltonen LA. A role for mitochondrial enzymes in inherited neoplasia and beyond. Nature Rev Cancer 2003 3 193-202 (Pubitemid 37328871)
169. Kantorovich V, King KS, Pacak K. SDH-related pheochromocytoma and paraganglioma. Best Pract Res Clin Endocrinol Metab 2010 24 415-442
170. Renard L, Godfraind C, Boon LM, Vikkula M. A novel mutation in the SDHD gene in a family with inherited paragangliomas - implications of genetic diagnosis for follow-up and treatment. Head Neck 2003 25 146-151 (Pubitemid 36133894)
171. Scheffler IE. Molecular genetics of succinate: quinolone oxidoreductase in eukaryotes. Prog Nucleic Acid Res Mol Biol 1998 60 267-315
172. Schiavi F, Boedeker CC, Bausch B, Peçzkowska M, Fuentes Gomez C, Strassburg T, Pawlu C, Buchta M, Salzmann M, Hoffmann MM, Berlis A, Brink I, Cybulla M, Muresan M, Walter MA, Forrer F, Välimäki M, Kawecki A, Szutkowski Z, Schipper J, Walz MK, Pigny P, Bauters C, Willett-Brozick JE, Baysal BE, Januszewicz A, Eng C, Opocher G, Neumann HPH. Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene. JAMA 2005 294 2057-2063 (Pubitemid 41539939)
173. van Nederveen FH, Gaal J, Favier J, Korpershoek E, Oldenburg RA, de Bruyn EM, Sleddens HF, Derkx P, Rivière J, Dannenberg H, Petri BJ, Komminoth P, Pacak K, Hop WC, Pollard PJ, Mannelli M, Bayley JP, Perren A, Niemann S, Verhofstad AA, de Bruïne AP, Maher ER, Tissier F, Méatchi T, Badoual C, Bertherat J, Amar L, Alataki D, Van Marck E, Ferrau F, François J, de Herder WW, Peeters MP, van Linge A, Lenders JW, Gimenez-Roqueplo AP, de Krijger RR, Dinjens WN. An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. Lancet Oncol 2009 10 764-771
174. Thakker RV. Multiple endocrine neoplasia type 1 (MEN1). Best Pract Res Clin Endocrinol Metab 2010 24 355-370
175. Wohllk N, Schweizer H, Erlic Z, Schmid KW, Walz MK, Raue F, Neumann HP. Multiple endocrine neoplasia type 2. Best Pract Res Clin Endocrinol Metab 2010 24 371-387
176. Raue F, Frank-Raue K. Update multiple endocrine neoplasia type 2. Fam Cancer 2010 9 449-457
177. Boedeker CC, Erlic Z, Richard S, Kontny U, Gimenez-Roqueplo AP, Cascon A, Robledo M, de Campos JM, van Nederveen FH, de Krijger RR, Burnichon N, Gaal J, Walter MA, Reschke K, Wiech T, Weber J, Rückauer K, Plouin PF, Darrouzet V, Giraud S, Eng C, Neumann HP. Head and Neck Paragangliomas in Von Hippel-Lindau Disease and Multiple Endocrine Neoplasia Type 2. J Clin Endocrinol Metab 2009 94 1938-1944
178. Kennedy DW, Nager GT. Glomus tumor and multiple endocrine neoplasia. Otolaryngol Head Neck Surg 1986 94 644-648 (Pubitemid 16095971)
179. DeAngelis LM, Kelleher MB, Post KD, Fetell MR. Multiple paragangliomas in neurofibromatosis: a new neuroendocrine neoplasia. Neurology 1987 37 129-133 (Pubitemid 17230121)
180. Neumann HPH, Cybulla M, Glaesker S, Coulin C, van Velthoven V, Berlis A, Hader C, Schaefer O, Treier M, Brink I, Schultze-Seemann W, Leiber C, Rückauer K, Junker B, Agostini HT, Hetzel A, Boedeker CC. Von-Hippel-Lindau-Erkrankung: Interdisziplinäre Patientenversorgung. Der Ophthalmologe 2007 104 119-126
181. Gaal J, van Nederveen FH, Erlic Z, Korpershoek E, Oldenburg R, Boedeker CC, Kontny U, Neumann HP, Dinjens WNM, de Krijger RR. Parasympathetic paragangliomas are part of the von Hippel-Lindau syndrome. J Clin Endocrinol Metab 2009 94 4367-4371
182. Bausch B, Boedeker CC, Berlis A, Brink I, Cybulla M, Walz MK, Januszewicz A, Letizia C, Opocher G, Eng C, Neumann HPH. Genetic and clinical investigation of pheochromocytoma: A 22-year experience, from Freiburg, Germany to international effort. Ann N Y Acad Sci 2006 1073 122-137 (Pubitemid 44912005)
183. Eisenhofer G, Lenders JW, Linehan WM, Walther MM, Goldstein DS, Keiser HR. Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. N Engl J Med 1999 340 1872-1879 (Pubitemid 29272667)
184. Schipper J, Maier W, Rosahl S, van Velthoven V, Berlis A, Boedeker CC, Laszig R, Teszler CB, Ridder GJ. Endolymphatic sac tumors: surgical management. J Otolaryngol 2006 35 387-394 (Pubitemid 46064067)
185. Ercolino T, Becherini L, Valeri A, Maiello M, Gagliano MS, Parenti G, Ramazzotti M, Piscitelli E, Simi L, Pinzani P, Nesi G, Degl'Innocenti D, Console N, Bergamini C, Mannelli M. Uncommon clinical presentations of pheochromocytoma and paraganglioma in two different patients affected by two distinct novel VHL germline mutations. Clin Endocrinol (Oxf) 2008 68 762-768 (Pubitemid 351533451)
186. Hull MT, Roth LM, Glover JL, Walker PD. Metastatic carotid body paraganglioma in von Hippel-Lindau disease. An electron microscopic study. Arch Pathol Lab Med 1982 106 235-239 (Pubitemid 12107695)
187. Gross DJ, Avishai N, Meiner V, Filon D, Zbar B, Abeliovich D. Familial pheochromocytoma associated with a novel mutation in the von Hippel-Lindau gene. J Clin Endocrinol Metab 1996 81 147-149 (Pubitemid 26035016)
188. Schimke RN, Collins DL, Rothberg PG. Functioning carotid paraganglioma in the von Hippel-Lindau syndrome. Am J Med Genet 1998 80 533-534 (Pubitemid 29002027)
189. Zanelli M, van der Walt JD. Carotid body paraganglioma in von Hippel-Lindau disease: a rare association. Histopathology 1996 29 178-181 (Pubitemid 26264445)
190. Ricketts CJ, Forman JR, Rattenberry E, Bradshaw N, Lalloo F, Izatt L, Cole TR, Armstrong R, Kumar VK, Morrison PJ, Atkinson AB, Douglas F, Ball SG, Cook J, Srirangalingam U, Killick P, Kirby G, Aylwin S, Woodward ER, Evans DG, Hodgson SV, Murday V, Chew SL, Connell JM, Blundell TL, Macdonald F, Maher ER. Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD. Hum Mutat 2010 31 41-51
191. Hensen EF, Jansen JC, Siemers MD, Oosterwijk JC, Vriends AH, Corssmit EP, Bayley JP, van der Mey AG, Cornelisse CJ, Devilee P. The Dutch founder mutation SDHD.D92Y shows a reduced penetrance for the development of paragangliomas in a large multigenerational family. Eur J Hum Genet 2010 18 62-66
192. Hes FJ, Weiss MM, Woortman SA, de Miranda NF, van Bunderen PA, Bonsing BA, Stokkel MP, Morreau H, Romijn JA, Jansen JC, Vriends AH, Bayley JP, Corssmit EP. Low penetrance of a SDHB mutation in a large Dutch paraganglioma family. BMC Med Genet 2010 11 11: 92
193. Hensen EF, Jordanova ES, van Minderhout IJ, Hogendoorn PC, Taschner PE, van der Mey AG, Devilee P, Cornelisse CJ. Somatic loss of maternal chromosome 11 causes parent-of-origin-dependent inheritance in SDHD-linked paraganglioma and phaeochromocytoma families. Oncogene 2004 23 4076-4083 (Pubitemid 38747938)
194. van Baars F, Cremers C, van den Brock P, Geerts S, Veldman J. Genetic aspects of nonchromaffin paraganglioma. Hum Genet 1982 60 305-309 (Pubitemid 12096384)
195. Bauters C, Vantyghem MC, Leteurtre E, Odou MF, Mouton C, Porchet N, Wemeau JL, Proye C, Pigny P. Hereditary phaeochromocytomas and paragangliomas: a study of five susceptibility genes. J Med Genet 2003 40 e75
196. Baysal BE, Willett-Brozick JE, Filho PA, Lawrence EC, Myers EN, Ferrell RE. An Alu-mediated partial SDHC deletion causes familial and sporadic paraganglioma. J Med Genet 2004 41 703-709 (Pubitemid 39208612)
197. Mannelli M, Ercolino T, Giachè V, Simi L, Cirami C, Parenti G. Genetic screening for pheochromocytoma: should SDHC gene analysis be included? J Med Genet 2007 44 586-587 (Pubitemid 47441767)
198. Erlic Z, Rybicki L, Peczkowska M, Golcher H, Kann PH, Brauckhoff M, Müssig K, Muresan M, Schäffler A, Reisch N, Schott M, Fassnacht M, Opocher G, Klose S, Fottner C, Forrer F, Plöckinger U, Petersenn S, Zabolotny D, Kollukch O, Yaremchuk S, Januszewicz A, Walz MK, Eng C, Neumann HP. European-American Pheochromocytoma Study Group. Clinical predictors and algorithm for the genetic diagnosis of pheochromocytoma patients. Clin Cancer Res 2009 15 6378-6385
199. Bayley JP, van Minderhout I, Weiss MM, Jansen JC, Oomen PH, Menko FH, Pasini B, Ferrando B, Wong N, Alpert LC, Williams R, Blair E, Devilee P, Taschner PE. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma. BMC Med Genet 2006 7 1
200. Vanharanta S, Buchta M, McWhinney SR, Virta SK, Peczkowska M, Morrison CD, Lehtonen R, Januszewicz A, Jarvinen H, Juhola M, Mecklin JP, Pukkala E, Herva R, Kiuru M, Nupponen NN, Aaltonen LA, Neumann HP, Eng C. Early onset renal cell carcinoma as novel extra-paraganglial component of SDHB-associated hereditable paraganglioma. Am J Hum Genet 2004 74 153-159 (Pubitemid 38085246)
201. Benn DE, Gimenez-Roqueplo AP, Reilly JR, Bertherat J, Burgess J, Byth K, Croxson M, Dahia PL, Elston M, Gimm O, Henley D, Herman P, Murday V, Niccoli-Sire P, Pasieka JL, Rohmer V, Tucker K, Jeunemaitre X, Marsh DJ, Plouin PF, Robinson BG. Clinical presentation and penetrance of pheochromocytoma/ paraganglioma syndromes. J Clin Endocrinol Metab 2006 91 827-836 (Pubitemid 43357746)
202. Burnichon N, Rohmer V, Amar L, Herman P, Leboulleux S, Darrouzet V, Niccoli P, Gaillard D, Chabrier G, Chabolle F, Coupier I, Thieblot P, Lecomte P, Bertherat J, Wion-Barbot N, Murat A, Venisse A, Plouin PF, Jeunemaitre X, Gimenez-Roqueplo AP. PGL.NET network. The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas. J Clin Endocrinol Metab 2009 94 2817-2827
203. Birch-Machin MA, Taylor RW, Cochran B, Ackrell BA, Turnbull DM. Late-onset optic atrophy, ataxia and myopathy associated with a mutation of a complex II gene. Ann Neurol 2000 48 330-335
204. Qin Y, Yao L, King EE, Buddavarapu K, Lenci RE, Chocron ES, Lechleiter JD, Sass M, Aronin N, Schiavi F, Boaretto F, Opocher G, Toledo RA, Toledo SP, Stiles C, Aguiar RC, Dahia PL. Germline mutations in TMEM127 confer susceptibility to pheochromocytoma. Nat Genet 2010 42 229-233
205. Carney JA, Sheps SG, Go VL, Gordon H. The triad of gastric leiomyosarcoma, functioning extra-adrenal paraganglioma and pulmonary chondroma. N Engl J Med 1977 296 1517-1518 (Pubitemid 8140566)
206. Grace MP, Batist G, Grace WR, Gillooley JF. Aorticopulmonary paraganglioma and gastric leiomyoblastoma in a young woman. Am J Med 1981 70 1288-1292 (Pubitemid 11072125)
207. Carney JA. Gastric stromal sarcoma, pulmonary chondroma, and extra-adrenal paraganglioma (Carney Triad): natural history, adrenocortical component, and possible familial occurrence. Mayo Clin Proc 1999 74 543-552
208. Carney JA, Stratakis CA. Familial paraganglioma and gastric stromal sarcoma: a new syndrome distinct from the Carney triad. Am J Med Genet 2002 108 132-139
209. McWhinney SR, Pasini B, Stratakis CA. International Carney Triad and Carney-Stratakis Syndrome Consortium. Familial gastrointestinal stromal tumors and germ-line mutations. N Engl J Med 2007 357 1054-1056 (Pubitemid 47367102)
210. Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, adopted on February 20, 1996. J Clin Oncol 1996 14 1730-1736
211. Neumann HPH, Bender BU, Reincke M, Eggstein S, Laubenberger J, Kirste G. Adrenal sparing surgery for pheochromocytoma. Brit J Surg 1999 84 94-97
212. Neumann HPH, Reincke M, Bender BU, Elsner R, Janetschek G. Preserved adrenocortical function after laparoscopic bilateral adrenal sparing surgery for hereditary Pheochromocytoma. J Clin Endocrinol Metab 1999 84 2608-2610 (Pubitemid 30641980)
213. Walz MK, Peitgen K, Neumann HPH, Janssen OE, Philipp T, Mann K. Endoscopic treatment of solitary, bilateral multiple, and recurrent pheochromocytomas and paragangliomas. World J Surg 2002 26 1005-1012 (Pubitemid 36920300)